Selected Publications

Thakrar AP.: Rapid Initiation of Extended-Release Buprenorphine-Evidence and Barriers. JAMA Netw Open 8: e2537331, Oct 2025.

Davis MH, Chertok J, Aronowitz S, French R, Perrone J, Thakrar AP, Huo S, Wilson JD, Bhadra-Heintz N, Lesniak L, Hecker A, Tolbert J, Lowenstein M.: Caring for Hospitalized Patients with Substance Use Disorders: An Interprofessional Needs Assessment Survey. Am J Med Open 14: 100116, Aug 2025.

Thakrar AP, Zwiebel SJ, Christine PJ, Spadaro A, Davis MH, Bhatia R, Rohacs N, Xu L, Perrone J, Lowenstein M.: Manifestations of potential xylazine withdrawal: A retrospective cohort study with nested case series. Drug Alcohol Depend 272: 112681, Jul 2025.

Yang WT, Meisner JA, Maguire C, Dyer KE, McFadden R, Thakrar AP, Dickinson DT, Berg D, Preston A, David MZ, Perrone J, Talati N, Degnan KO.: Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds. Open Forum Infect Dis 12: ofaf299, May 2025.

Berk J, Rose M, Thakrar AP.: Low-Dose Initiations of Buprenorphine in the Fentanyl Era-A Search for Evidence-Based Approaches to an Evolving Crisis. JAMA Netw Open 8: e2456261, Jan 2025.

French R, McFadden R, Lowenstein M, O'Donnell N, Perrone J, Aronowitz S, Thakrar AP, Schachter A, Turi E, Compton P.: A qualitative study exploring the feasibility and acceptability of embedding an overdose prevention sites in a U.S. hospital. J Subst Use Addict Treat Jan 2025.

Lutz L, MD; McFadden R, RN, MPH; Xu L, MS; Ranvir Bhatia, MD; M. Holliday Davis, MA; Natasa Rohacs, BA; Jenny Wei, MD; Jeanmarie Perrone, MD; Margaret Lowenstein, MD, MPhil, MSHP; Thakrar AP, MD, MS: Wound Characteristics Among Patients Exposed to Xylazine. JAMA Dermatology Nov 2024.

Barr GA, Schmidt HD, Thakrar AP, Kranzler HR, Liu R.: Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liability. CNS Neurosci Ther Oct 2024.

Thakrar AP, Christine PJ, Siaw-Asamoah A, Spadaro A, Faude S, Snider CK, Delgado MK, Lowenstein M, Kampman K, Perrone J, Nelson LS, Kilaru AS.: Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl. JAMA Network Open 7: e2435895, Sep 2024.

Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E.: Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review. JAMA Internal Medicine 184: 691-701, Jun 2024.